Revenue Breakdown
Composition ()
No data
Revenue Streams
Apyx Medical Inc (APYX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Advance Energy, accounting for 85.9% of total sales, equivalent to $11.06M. Another important revenue stream is OEM. Understanding this composition is critical for investors evaluating how APYX navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Apyx Medical Inc maintains a gross margin of 64.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -6.46%, while the net margin is -15.18%. These profitability ratios, combined with a Return on Equity (ROE) of -172.18%, provide a clear picture of how effectively APYX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, APYX competes directly with industry leaders such as CRDF and SKIN. With a market capitalization of $135.40M, it holds a significant position in the sector. When comparing efficiency, APYX's gross margin of 64.43% stands against CRDF's 100.00% and SKIN's 64.59%. Such benchmarking helps identify whether Apyx Medical Inc is trading at a premium or discount relative to its financial performance.
